Advancing Genetic
Diagnostics for
Precise Medicine.

Impact Genetics provides cost-effective, high quality genetic testing for select diseases.

In collaboration with our leading scientists and clinical care providers, we continually refine tests to maximize sensitivity. New scientific discoveries, genetic data and clinical knowledge flow freely to maximize health impact. Impact Genetics’ service delivery team is committed to supporting doctors and genetic specialists with outstanding service.

  • June 4th, 2014 – NEW TEST FOR UVEAL MELANOMA. Impact has launched a new prognostic test for Uveal Melanoma. This genetic test identifies the risk of metastasis, indicating survival prognosis in patients with Uveal Melanoma.
    More information.


We offer the following clinical genetic tests in our CAP/CLIA certified lab.

Why choose us?
  • Cost effective
  • Documented high diagnostic sensitivity
  • Provided by disease experts
  • Flexible billing and personal support
  • Quick turn-around times
  • Comprehensive and informative reports

More about our services

News and Events
Monday, February 16th 2015 is Family Day in Ontario – a statutory holiday. Our lab and office will be closed and we will not be receiving samples that day. More information
Impact Genetics has launched a new prognostic test for Uveal Melanoma. More details here.
Impact’s Retinoblastoma Genetic Test includes the MYCN gene. More details here.

More news and events